Status:
COMPLETED
Nevirapine Levels and Fluconazole
Lead Sponsor:
Bamrasnaradura Infectious Diseases Institute
Conditions:
Nevirapine
Fluconazole
Eligibility:
All Genders
15+ years
Brief Summary
Nevirapine (NVP)-based antiretroviral therapy (ART) has been commonly used in many developing countries due to its affordability and feasibility. Nonetheless, the potential drug-drug interaction betwe...
Eligibility Criteria
Inclusion
- HIV-infected patients \>15 years of age,
- naïve to antiretroviral therapy,
- were initiated with a NVP-based ART regimen,
- used NVP 200-mg once-daily lead-in dose, prior to escalation to 200 mg twice daily.
Exclusion
- creatinine level was higher than 2.0 mg/ml
- liver aminotransferase enzyme was higher than five times of upper normal limit
- receiving a medication that has drug-drug interactions with NVP or FLU
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00309582
Last Update
April 3 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.